Cover Image
Market Research Report
Product code 
1086213

Liquid Biopsy Market, By Biomarker Type (CTC, ctNA, Exosomes), By Sample Type, By Disease Indication, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published: | Coherent Market Insights | 180 Pages | Delivery time: 2-3 business days

Price

Back to Top
Liquid Biopsy Market, By Biomarker Type (CTC, ctNA, Exosomes), By Sample Type, By Disease Indication, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Published: May 6, 2022
Coherent Market Insights
Content info: 180 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

Liquid biopsy is an advanced non-invasive cancer diagnostic technique that uses bio-fluids such as blood, cerebrospinal fluid (CSF), plasma, and urine for detecting cancer. Liquid biopsy uses circulating nucleic acids, circulating tumor cells (CTC), and exosomes as biomarkers for diagnosis of cancer. Increasing demand for non-invasive diagnostic procedures is expected to boost growth of the global liquid biopsy market over the forecast period. Furthermore, increasing prevalence of cancer is a major factor propelling growth of the global liquid biopsy market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global Liquid Biopsy and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global Liquid Biopsy based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Biocept, Inc., Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA, Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon Biosystems, Pathway Genomics Corporation, and Sysmex Corporation.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Liquid Biopsy report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Liquid Biopsy Market, By Biomarker Type:
  • CTC (Circulating Tumor Cells)
  • ctNA (Circulating Tumor Nucliec Acids)
  • Exosomes
  • Liquid Biopsy Market, By Sample Type:
  • Blood
  • Urine
  • Others
  • Liquid Biopsy Market, By Disease Indication:
  • Lung Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Others
  • Liquid Biopsy Market, By End User:
  • Hospitals
  • Cancer Institutes
  • Academic Institutes
  • Diagnostic Centers
  • Liquid Biopsy Market, By Region:
  • North America

? By Biomarker Type:

? CTC (Circulating Tumor Cells)

? ctNA (Circulating Tumor Nucliec Acids)

? Exosomes

? By Sample Type

? Blood

? Urine

? Others

? By Disease Indication

? Lung Cancer

? Gastrointestinal Cancer

? Prostate Cancer

? Breast Cancer

? Colorectal Cancer

? Leukemia

? Others

? By End User

? Hospitals

? Cancer Institutes

? Academic Institutes

? Diagnostic Centers

? By Country:

? U.S.

? Canada

  • Latin America

? By Biomarker Type:

? CTC (Circulating Tumor Cells)

? ctNA (Circulating Tumor Nucliec Acids)

? Exosomes

? By Sample Type

? Blood

? Urine

? Others

? By Disease Indication

? Lung Cancer

? Gastrointestinal Cancer

? Prostate Cancer

? Breast Cancer

? Colorectal Cancer

? Leukemia

? Others

? By End User

? Hospitals

? Cancer Institutes

? Academic Institutes

? Diagnostic Centers

? By Country:

? Brazil

? Mexico

? Argentina

? Rest of Latin America

  • Europe

? By Biomarker Type:

? CTC (Circulating Tumor Cells)

? ctNA (Circulating Tumor Nucliec Acids)

? Exosomes

? By Sample Type

? Blood

? Urine

? Others

? By Disease Indication

? Lung Cancer

? Gastrointestinal Cancer

? Prostate Cancer

? Breast Cancer

? Colorectal Cancer

? Leukemia

? Others

? By End User

? Hospitals

? Cancer Institutes

? Academic Institutes

? Diagnostic Centers

? By Country:

? Germany

? U.K.

? France

? Italy

? Spain

? Russia

? Rest of Europe

  • Asia Pacific

? By Biomarker Type:

? CTC (Circulating Tumor Cells)

? ctNA (Circulating Tumor Nucliec Acids)

? Exosomes

? By Sample Type

? Blood

? Urine

? Others

? By Disease Indication

? Lung Cancer

? Gastrointestinal Cancer

? Prostate Cancer

? Breast Cancer

? Colorectal Cancer

? Leukemia

? Others

? By End User

? Hospitals

? Cancer Institutes

? Academic Institutes

? Diagnostic Centers

? By Country:

? China

? India

? Japan

? Australia

? South Korea

? ASEAN

? Rest of Asia Pacific

  • Middle East

? By Biomarker Type:

? CTC (Circulating Tumor Cells)

? ctNA (Circulating Tumor Nucliec Acids)

? Exosomes

? By Sample Type

? Blood

? Urine

? Others

? By Disease Indication

? Lung Cancer

? Gastrointestinal Cancer

? Prostate Cancer

? Breast Cancer

? Colorectal Cancer

? Leukemia

? Others

? By End User

? Hospitals

? Cancer Institutes

? Academic Institutes

? Diagnostic Centers

? By Country:

? GCC

? Israel

? Rest of Middle East

  • Africa

? By Biomarker Type:

? CTC (Circulating Tumor Cells)

? ctNA (Circulating Tumor Nucliec Acids)

? Exosomes

? By Sample Type

? Blood

? Urine

? Others

? By Disease Indication

? Lung Cancer

? Gastrointestinal Cancer

? Prostate Cancer

? Breast Cancer

? Colorectal Cancer

? Leukemia

? Others

? By End User

? Hospitals

? Cancer Institutes

? Academic Institutes

? Diagnostic Centers

? By Country:

? South Africa

? Central Africa

? North Africa

  • Company Profiles
  • Biocept, Inc. *

? Company Overview

? Product Portfolio

? Key Highlights

? Financial Overview

? Strategies

  • Qiagen N.V
  • Trovagene, Inc.
  • Janssen Global Services, LLC
  • MDxHealth SA
  • Natera, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Silicon Biosystems
  • Pathway Genomics Corporation
  • Sysmex Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI1223

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Products & Services
    • Market Snippet, By Sample
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Regulatory Scenario
  • Technological Evolution
  • Mergers & Acquisition
  • Pipeline Analysis
  • Recently Launched Products

4. Global Liquid Biopsy Market, By Products & Services, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Reagents & Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Equipments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Liquid Biopsy Market, By Sample, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cell Free DNA (cfDNA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Circulating Tumor Cells (CTC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Exosomes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Liquid Biopsy Market, By Application, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Oncology Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Noninvasive Prenatal Testing (NIPT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Transplant Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Liquid Biopsy Market, By End User, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Patients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Liquid Biopsy Market, By Regions, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Products & Services, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Products & Services, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Products & Services, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Products & Services, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Products & Services, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Products & Services, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Roche AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Natera Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Laboratory Corporation of America Holding
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Qiagen N.V.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Exact Sciences Corp.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Biocept, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Genomic Health Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Guardant Health
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • CareDx Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Adaptive Biotechnologies Corporatio
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Biocartis SA.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact